Education & Training

Most Recent Trainings

• Share

  Opioids, Dentistry and Addiction: The Dentist’s Role in Treating Pain

  Target Audience(s): Dentists, Interprofessional Teams

  Organization(s): American Dental Association

  Topic(s): Introduction to OUDs, Overdose, Pain, Practice Issues, Special Topics

  Presenter(s): Sharon Parsons, DDS and David Kimberly, DDS, MD

  Join the American Dental Association and Drs. Sharon Parsons and David Kimberly for this one hour webinar that will cover the important topic of Opioids, Dentistry and Addiction: The Dentist’s Role in Treating Pain. The United States experienced a tragic rise in drug overdose deaths in 2020, which was largely caused by inappropriate use of opioids. Attendees will hear from a practicing dentist and an oral surgeon about the positive role dentists can play to help mitigate the opioid crisis. Additionally, attendees will gain a better understanding of the relationship between substance use and addiction, as well as learn about treatments currently available for acute pain.
• Share

  Treatments for Stimulant Use Disorder: Evaluation of the Evidence

  Target Audience(s): Nurses, Pharmacists, Physician Assistants, Physicians, Social Workers

  Organization(s): American Academy of Addiction Psychiatry

  Topic(s): Introduction to OUDs

  Presenter(s): Steve Shoptaw PhD

  This webinar will review evidence on medications and behavioral therapies for stimulant use disorder. It will engage a discussion of the potential for using medications and behavioral therapies that have efficacy in local treatment clinics – and the steps needed to be able to accomplish this.
• Share

  Digital Therapeutics for Substance Use Disorders: Research Priorities and Clinical Validation

  Target Audience(s): Nurses, Pharmacists, Physician Assistants, Physicians

  Organization(s): American Academy of Addiction Psychiatry

  Topic(s): Treatment Modalities

  Presenter(s): Will M. Aklin, PhD

  There are effective treatments for Substance Use Disorders (SUDs), though they do not work for all patients and efficacy decreases over the long-term. As evidenced during the COVID-19 pandemic, traditional methods of delivering treatment have limitations and can be difficult or even impossible to access. Thus, there is an urgent need for new therapeutic options. This webinar will highlight research to support the development of safe and effective Digital Therapeutics (DTx), discuss strategies to accelerate their delivery to patients, and improve SUD treatment outcomes. DTx, a subset of digital health, consists of high-quality software programs to prevent, manage, or treat medical conditions. DTx that meet the definition of a medical device go through an FDA regulatory review process to be legally marketed in the US. The ultimate goal of this webinar is to illuminate NIH-research priorities and clinically validated DTx options for patients with SUDs.